Placement of $10m Closed Significantly Oversubscribed
Filed with ASX · · 2 pages · English
Story so far
Earlier from Argent Biopharma
- Australian Legislation Changes Fast Track MXC
- Cannabinoid Extraction Facility On Target Q2 Production
- Medical Cannabis Clinical Study Commencing
- Panax Acquisition Completed
- Commencement of Dermatological Clinical Trials
Later from Argent Biopharma
- European API Extraction Facility Completed
- Successful MXC First Cannabinoid Production
- New EU Sales Agreements Signed For MGC Derma
- Strategic Agreement Signed with RMIT
- CEO Appointment
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma